Parkinson’s Disease – Patient Roleplay
14 Jan 2021
An exclusive patient roleplay, featuring the following industry leading expert: Donald Grosset BSc Hons & Parkinson’s Disease patient, John Sterling. CME...
Neurology
Movement Disorders
Latest Videos
Optimising ON Time – Advanced Parkinson’s Disease
30 Dec 2020
An exclusive panel discussion, featuring the following industry leading experts: Donald Grosset BSc Hons, MBChB, MD; Fabrizio Stocchi MD, PhD & Joaquim Ferreira MD,...
Motor Symptoms and Therapy Choices – Advanced Parkinson’s Disease
30 Nov 2020
An exclusive panel discussion, featuring the following industry leading experts: Bas Bloem, MD, PhD; Per Odin MD, PhD & Olivier Rascol, MD, PhD CME ACCREDITED...
Tailoring Levodopa according to patient characteristics
02 Nov 2020
An exclusive duo interview, featuring the following industry leading experts: Professor Werner Poewe, & Professor Bas Bloem. This duo interview was supported by an...
Living with Parkinson’s – The Impact of Treatment Choices
15 Oct 2020
An exclusive panel discussion, featuring the following industry leading experts: Werner Poewe, MD, PhD; Angelo Antonini MD, PhD & Pablo Mir, MD, PhD CME ACCREDITED...
Role, Function and Effect of Catechol-O-Methyl Transferase In Humans And Parkinson Disease
09 Oct 2020
An exclusive 3 part 1:1 interview, featuring industry leading expert; Professor Fabrizio Stocchi Part 1 A knowledge of the COMT mechanism of action in humans and the...
Clinical Data of Opicapone ▼ for the Management of Motor Fluctuations in PD Patients
25 Sep 2020
Prof. Joaquim Ferreira Highlights of the BIAL sponsored symposium at the 2020 MDS congress
Clinical Manifestations, Pathophysiology and Impact of Motor Fluctuations in Patients
25 Sep 2020
Prof. Hubert Fernandez Highlights of the BIAL sponsored symposium at the 2020 MDS congress
Modulation of Levodopa Metabolism, The Role of COMT Inhibition and Opicapone ▼ Pharmacologic Profile
25 Sep 2020
Prof. Cheryl Waters Highlights of the BIAL sponsored symposium at the 2020 MDS congress
Nonmotor Symptoms In Parkinson’s Disease Recognition & Management
09 Jun 2020
An exclusive one to one interview with Professor Per Odin, Head of Office, Neurology, Lund University, Sweden This interview was supported by an independent educational...
A2A Receptor Antagonists: Potential adjuvant therapies for levodopa optimisation
18 May 2020
An exclusive panel discussion, featuring the following industry leading experts: Werner Poewe, Per Odin & Angelo Antonini This roundtable discussion was supported...
The impact of COVID-19 for families with Parkinson’s Disease
13 May 2020
An exclusive one to one interview with Professor Bas Bloem, Parkinson Centre Nijmegan (ParC), Radboud University Medical Centre This interview was supported by an...
Diagnosis and Management of Levodopa Response Fluctuations in Parkinson’s Disease
05 Mar 2020
An exclusive one to one interview with Professor Werner Poewe, MD, PhD, Innsbruck Medical University, Innsbruck, Austria This interview was supported by an independent...
Oruen Testimonial by Professor Werner Poewe
19 Feb 2020
A testimonial on Oruen by Professor Werner Poewe, a valued board member. Professor Werner Poewe Clinical Neurologist & Professor of Neurology Innsbruck Medical...
Early use of Levodopa vs Levodopa-sparing strategies
08 Nov 2019
An exclusive one to one interview with Professor Joaquim Ferreira, Associate Professor of Neurology and Clinical Pharmacology (FMUL), Lisbon, Portugal This interview...
Diagnosis and Management of Wearing Off – Repositioning COMTi and Response Duration in Levodopa Optimisation
07 Nov 2019
This roundtable discussion was supported by an independent educational grant by Bial HOW TO OBTAIN CME CREDITS Participants requesting CME credits are required to...
Parkinson’s Life podcast: a voice for the global Parkinson’s community. LISTEN TO THE NEW EPISODE 5
18 Oct 2019
The EPDA website Parkinson’s Life – the online lifestyle magazine offering a voice to the global Parkinson’s community – launched its first podcast in May 2019....
Recognition and Management of Wearing Off Utilisation of Catechol-O-Methyltransferase (COMT) Inhibitors – Olivier Rascol
16 Oct 2019
This interview was supported by an independent educational grant by Bial HOW TO OBTAIN CME CREDITS Participants requesting CME credits are required to complete the...
Prof. David Devos, MD, PhD Expert opinion on early start of infusion therapies in PD (interview during MDS Congress, Nice, France, 24.09.2019)
11 Oct 2019
Early vs Late Use Of Levodopa – Angelo Antonini
12 Sep 2019
This interview was supported by an independent educational grant by Bial HOW TO OBTAIN CME CREDITS Participants requesting CME credits are required to complete the...
People over the world talk about their Parkinson’s – Chapter 1
29 Apr 2019
EPDA #UniteForParkinsons
29 Apr 2019
Roundtable discussion, Professors Werner Poewe, Angelo Antonini and Oliver Rascol discuss: “Is Delaying Levodopa a Disservice to Patients?”
02 Aug 2018
Once you have viewed the content in the video, click here to download and review the accompanying slide deck.
Management of Parkinson’s Disease: From Science to Clinical Wisdom, Prof. Werner Poewe, Prof. Fabrizio Stocchi, Prof. Georg Ebersbach & Dr. Francesca Morgante
09 Jul 2018
Chairman’s introduction Prof. Werner Poewe Innsbruck, Austria Current Treatment of Fluctuations Prof. Fabrizio Stocchi Rome, Italy Managing Motor Fluctuations:...
What Is My Pd Journey?
14 Feb 2017
My PD Journey from Oruen on Vimeo.
New Developments In Parkinson’s Disease Management: Interviews With The Experts
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
New Developments In Parkinson’s Disease Management: Interviews With The Experts
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Critical Case Considerations
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Am Impakt: Apomorphine For Morning Akinesia Trial – Results
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Delayed ON And Wearing OFF – Complications
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
Introduction To The Symposium
14 Nov 2014
APO-go® Apomorphine hydrochloride PRESCRIBING INFORMATION Consult Summary of Product Characteristics before prescribing. Uses Treatment of motor fluctuations (“on-off”...
“I am David”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
14 Jan 2014
Watch this authentic and inspirational video about a dystonia patient telling their own dystonia story and how they cope with the impact of the disease. Dystonia...
“I am Cheryl”.. Quality Of Life Perspectives From A Patient With Cervical Dystonia
14 Jan 2014
Watch this authentic and inspirational video about a dystonia patient telling their own dystonia story and how they cope with the impact of the disease. Dystonia...
Latest Posts
Changing the paradigm for treating motor fluctuations in Parkinson’s: advancements in COMT inhibition
12 Jan 2021
The Next Frontier for Parkinson’s disease and Movement Disorders: The Middle East, North Africa and South Asia (MENASA) region
09 Dec 2020
An exclusive panel discussion, featuring the following global leading experts: Jawad A. Bajwa, MD, Jose Obeso MD, PhD & Christopher G....
What’s New In Parkinson’s Rating Scales?
27 Jul 2017
Rating scales aid Parkinson’s evaluation and are an important assessment tool for healthcare professionals. However, existing scales have...
Botulinum Neurotoxin And Dystonia: A Case For Greater Flexibility In Treatment Regimens?
12 Jan 2017
The causes of dystonia are not fully understood and although currently available treatments can provide effective symptomatic relief, they...
Neuromelanin MR Imaging In Parkinson’s Disease
01 Jul 2016
The development and application of neuromelanin sensitive MR imaging has allowed the detection of significant changes in the substantia...
The Clinical Validation Of Objective Measurement Of Movement In Parkinson’s Disease
30 Jun 2016
Introduction Home based objective measures of bradykinesia and dyskinesia will be important in managing Parkinsons Disease (PD). The Aim...
Plotting A Better Pathway For Parkinson’s Disease: The My PD Journey Project
30 Jun 2016
A clinical scale that takes a broader, deeper view of PD symptoms is the latest milestone in a collaborative effort to resolve multiple...
Parkinson’s Life – A new ‘Webzine’ For The International Parkinson’s Community Now Live!
28 Oct 2015
A new and innovative magazine-style website has been launched to inspire and inform the international Parkinson’s community. Parkinson’s...
Treatment Options For Atypical Parkin-Sonisms
13 May 2015
Success in treating patients with atypical parkinsonisms remains exceedingly low. This finding probably relates to the widespread...
The Role Of Apomorphine In The Effective Management Of Parkinson’S Disease – Highlights From Cony 2014
29 Aug 2014
The 8th World Congress on Controversies in Neurology (CONy) held in Berlin in May 2014 provided a forum for neurologists and other...
Coming Up Next: Managing Motor Complications In Parkinson’s Disease
11 Sep 2013
João Massano, MD Department of Neurology, Hospital Pedro Hispano/ULS Matosinhos, Portugal Department of Clinical Neurosciences and...
Natural Toxins: Their Roles In Developing PD
05 Dec 2012
Dr. Mohamed Salama Head of Experimental Neurology Unit MERC, Mansoura University, Egypt In rural living, individuals are exposed to...
Drug Dosage, Gender Affect Impulsivity Prognosis in Parkinson’s
07 Sep 2012
The development and resolution of impulse control disorders in patients with Parkinson’s disease appears to be largely reliant on gender,...
Nocturnal Sleep Boosts Working Memory Training in Parkinson’s
03 Sep 2012
Nocturnal sleep enhances working memory training in patients with Parkinson’s disease but not in those with Lewy body dementia, results...
Physiotherapy Found to Have Short-Term Benefit in Parkinson’s
29 Aug 2012
Existing data support the use of physiotherapy in the treatment of Parkinson’s disease in the short term, but larger, randomized...
Drug For Alzheimer’s, Parkinson’s And MS Shows Promise
21 Aug 2012
A “one-size-fits-all” new class of drugs that targets a particular type of brain inflammation is showing early promise for the...
Family History Tops Parkinson’s Disease Risk Factors
01 Aug 2012
A family member with Parkinson’s disease confers the strongest risk for developing the disease, according to findings from the largest and...
Voice Disturbance Analysis Detects Parkinson’s
29 Jul 2012
Evidence that voice disturbances might be an additional clue to making a diagnosis of Parkinson’s disease was recently supported by a...
MCI in Parkinson’s Linked to Frontostriatal Dysfunction
26 Jul 2012
Parkinson’s disease patients with mild cognitive impairment have dysfunctional circuitry in brain networks involving the right dorsal...
Risk Factors Identified for Impulse Control Disorders in Parkinson’s
07 Jun 2012
Dopamine agonist–induced impulse control disorders may be more likely in Parkinson’s disease patients who smoke, drink, or consume...
Rotigotine Patch Has Favorable Results in Parkinson’s, Restless Legs
25 May 2012
A reformulated version of the previously withdrawn Neupro rotigotine patch had favorable results in separate studies of patients with...
Ocular Tremor a Possible Biomarker for Early Parkinson’s Disease
10 Apr 2012
Ocular fixation instability, also known as ocular tremor, is a pervasive and highly specific feature among patients with Parkinson’s...
Study Hints at Statins’ Protective Effect Against Parkinson’s
13 Mar 2012
Regular users of statins had a “marginally significant” lower risk of developing Parkinson’s disease than did nonusers in a...
Weight Lifting Improves Physical Function in Parkinson’s
20 Feb 2012
A 2-year weight-lifting program improved physical symptoms of Parkinson’s disease – including tremor – and seemed to slow their...
Tai Chi Improved Postural Stability in Parkinson’s Disease
09 Feb 2012
Tai chi improved postural stability and other functional outcomes in patients with mild to moderate Parkinson’s disease to a significantly...
Disparities Seen in Care of Parkinson’s Patients : Better clinical care associated with neurologists was often unavailable to women or minorities.
03 Dec 2011
Major Finding: Women and blacks with Parkinson’s disease both had 23% lower odds of receiving care from a neurologist than did men...
Symptom Triad May Identify Parkinson’s Risk
20 Nov 2011
Major Finding: Significantly more individuals with hyposmia had DAT levels of 65% or lower, compared with normosmic individuals (11% vs....
Exercise Improved Some Cognitive Function in Parkinson’s
04 Nov 2011
Major Finding: Exercise and medication use significantly improved cognitive function in patients with Parkinson’s disease based on...